Arcturus Therapeutics : Additional Application for Booster Dose of ARCT-154, Self-Amplifying mRNA Vaccine against COVID-19, Submitted in Japan

Additional Application for Booster Dose of ARCT-154,


Self-Amplifying mRNA Vaccine against COVID-19, Submitted in Japan


Meiji Holdings Co., Ltd. Announces that...

Related Keywords

Australia ,Japan ,Meiji ,Hokkaido ,Wuhan ,Hubei ,China ,Japanese ,Seika Pharma ,Arcalis Inc ,Arcturus Therapeutics Inc ,Axcelead Inc ,Meiji Seika Pharma Co Ltd ,Arcturus Therapeutics Holdings Inc ,Meiji Holdings Co Ltd ,Medicines Company ,Additional Application ,Booster Dose ,Arcturus Therapeutics ,Meiji Seika Pharma ,Minami Soma City ,Therapeutics Holdings ,